Systemic mastocytosis with associated hematologic neoplasm (SM-AHN) presents unique diagnostic and treatment challenges. In this Medscape-certified activity, experts discuss the complex patient journey, from delayed diagnosis to individualized…
Avapritinib, branded as Ayvakit, became the first FDA-approved treatment for indolent systemic mastocytosis (ISM) in 2023, marking a major advancement for patients. ISM, driven by the KIT D816V…
Erin Dunbar, MD, of @PiedmontHealth, Minesh Mehta, MD, of @MiamiCancerInst, Zosia Piotrawska, MD, MHS, of @MGHMedicine, and Rohan Ramakrishna, MD, of @WeillCornell discuss #brainmetastases in #lungcancer.
